Vanessa Preumont
YOU?
Author Swipe
View article: Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review
Cardiometabolic insights in cystic fibrosis and highly effective modulator therapies: a narrative review Open
Graphical Abstract Abstract Alongside pulmonary and nutritional benefits, highly effective modulator therapies (HEMT) can promote an increase in body fat and raise the prevalence of overweight/obesity, dyslipidemia, and hypertension in pat…
View article: Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial
Cost-effectiveness of advanced hybrid closed loop therapy compared to standard insulin therapy for type 1 diabetes in pregnancy: an economic evaluation of the CRISTAL trial Open
Diabetes Liga Research Fund and Medtronic.
View article: Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium Open
View article: Advanced hybrid closed loop therapy compared to standard insulin therapy intrapartum and early postpartum in women with type 1 diabetes: a secondary observational analysis from the randomized controlled CRISTAL trial
Advanced hybrid closed loop therapy compared to standard insulin therapy intrapartum and early postpartum in women with type 1 diabetes: a secondary observational analysis from the randomized controlled CRISTAL trial Open
ObjectiveTo determine efficacy and safety of intrapartum and early postpartum advanced hybrid closed loop (AHCL) therapy compared to standard insulin therapy (SoC) in pregnant individuals with type 1 diabetes (T1D).Research Design and Meth…
View article: Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial Open
View article: Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetes
Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetes Open
The composite index DIPIc is a suitable, less invasive screening method for CFRD, which enables to avoid many OGTTs.
View article: Advances in cystic fibrosis-related diabetes: Current status and future directions
Advances in cystic fibrosis-related diabetes: Current status and future directions Open
CFRD management is an ongoing concern. Optimal care has reduced the negative impact of CFRD on lung function, nutrition, and survival. Increasing prevalence of CFRD and prolonged lifespan lead to more microvascular complications. New scree…
View article: Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes
Combined CFTR modulator therapies are linked with anabolic benefits and insulin-sparing in cystic fibrosis-related diabetes Open
Combined CFTR modulator therapies are correlated with a decrease in insulin doses and positive effects on BMI and FEV1. HOMA indices did not change on tezacaftor + ivacaftor among CF patients without diabetes.
View article: Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol
Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol Open
Background Despite increasing use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII, insulin pumps) in type 1 diabetes (T1D) in pregnancy, achieving recommended pregnancy glycaemic targets (3.5–7.8 m…
View article: Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ? Open
Metabolic dysfunction-associated fatty liver disease (MAFLD) is the evidence of steatosis in the setting of a metabolic risk condition such as type 2 diabetes mellitus (T2DM). Indeed, T2DM and liver steatosis share common pathophysiologica…
View article: Contraception and diabetes: Which modalities should we consider in 2021?
Contraception and diabetes: Which modalities should we consider in 2021? Open
View article: Impact of flash glucose monitoring on glycaemic control and quality of life in patients with type 1 diabetes: A 18-month follow-up in real life
Impact of flash glucose monitoring on glycaemic control and quality of life in patients with type 1 diabetes: A 18-month follow-up in real life Open
View article: Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial Open
View article: Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials
Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials Open
View article: Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patients
Long-term effects of GLP-1 receptor agonists in type 2 diabetic patients: A retrospective real-life study in 131 patients Open
View article: Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests
Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests Open
To the Editor,\nHereby we report a rare interference that affected the thyroid function tests in two patients seen in our outpatient clinic between May and June 2017. In our laboratory, thyroid-stimulating hormone (TSH) is measured with a …
View article: An elevated 1-h post- load glucose level during the oral glucose tolerance test detects prediabetes
An elevated 1-h post- load glucose level during the oral glucose tolerance test detects prediabetes Open
View article: Hypoglycaemia revealing heterozygous insulin receptor mutations
Hypoglycaemia revealing heterozygous insulin receptor mutations Open